{"title":"非囊性纤维化支气管扩张:儿科医院的流行病学概况","authors":"Brenda Reis, Ângelo Quadros, Raisa Pinheiro","doi":"10.25060/residpediatr-2023-941","DOIUrl":null,"url":null,"abstract":"Objectives: to describe the epidemiological profile of patients with non-cystic fibrosis bronchiectasis in a pediatric hospital and to expand the knowledge of this comorbidity in the pediatric population. Methods: Chest CT scans performed from January 2016 to January 2020 in a pediatric care service were selected. The reports were consulted, verifying those with compatible criteria currently accepted for the diagnosis of bronchiectasis. The medical records of those selected underwent a review process in search of the variables analyzed. Patients diagnosed with cystic fibrosis and with outdated medical records were excluded. Results: Of the 2319 reports studied, 42 patients were identified. Among these, 59.5% were female, 66.7% were followed up at a pneumopediatrics outpatient clinic, and the mean age at the time of imaging diagnosis was 9.3 years (±4.9). At follow-up, 57.1% of patients underwent spirometry and 35.7% underwent sputum culture. The most observed bacterial growth was that of Pseudomonas aeruginosa (33.4%) and the most frequent spirometric pattern was restrictive (29.2%). Of the presumptive etiologies, the most prevalent was recurrent pneumonia (21.4%), followed by bronchiolitis obliterans (14.3%) and collagen diseases (14.3%). Conclusions: The results found in this study allowed a better characterization of this subgroup of patients. In addition, the importance of diagnosing non-cystic fibrosis bronchiectasis is reinforced, as its therapy requires specific and individualized management.","PeriodicalId":338092,"journal":{"name":"Residência Pediátrica","volume":"41 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"1900-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"NON-CYSTIC FIBROSIS BRONCHIECTASIS: AN EPIDEMIOLOGICAL PROFILE IN A PEDIATRIC HOSPITAL\",\"authors\":\"Brenda Reis, Ângelo Quadros, Raisa Pinheiro\",\"doi\":\"10.25060/residpediatr-2023-941\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Objectives: to describe the epidemiological profile of patients with non-cystic fibrosis bronchiectasis in a pediatric hospital and to expand the knowledge of this comorbidity in the pediatric population. Methods: Chest CT scans performed from January 2016 to January 2020 in a pediatric care service were selected. The reports were consulted, verifying those with compatible criteria currently accepted for the diagnosis of bronchiectasis. The medical records of those selected underwent a review process in search of the variables analyzed. Patients diagnosed with cystic fibrosis and with outdated medical records were excluded. Results: Of the 2319 reports studied, 42 patients were identified. Among these, 59.5% were female, 66.7% were followed up at a pneumopediatrics outpatient clinic, and the mean age at the time of imaging diagnosis was 9.3 years (±4.9). At follow-up, 57.1% of patients underwent spirometry and 35.7% underwent sputum culture. The most observed bacterial growth was that of Pseudomonas aeruginosa (33.4%) and the most frequent spirometric pattern was restrictive (29.2%). Of the presumptive etiologies, the most prevalent was recurrent pneumonia (21.4%), followed by bronchiolitis obliterans (14.3%) and collagen diseases (14.3%). Conclusions: The results found in this study allowed a better characterization of this subgroup of patients. In addition, the importance of diagnosing non-cystic fibrosis bronchiectasis is reinforced, as its therapy requires specific and individualized management.\",\"PeriodicalId\":338092,\"journal\":{\"name\":\"Residência Pediátrica\",\"volume\":\"41 1\",\"pages\":\"0\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"1900-01-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Residência Pediátrica\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.25060/residpediatr-2023-941\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Residência Pediátrica","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.25060/residpediatr-2023-941","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
NON-CYSTIC FIBROSIS BRONCHIECTASIS: AN EPIDEMIOLOGICAL PROFILE IN A PEDIATRIC HOSPITAL
Objectives: to describe the epidemiological profile of patients with non-cystic fibrosis bronchiectasis in a pediatric hospital and to expand the knowledge of this comorbidity in the pediatric population. Methods: Chest CT scans performed from January 2016 to January 2020 in a pediatric care service were selected. The reports were consulted, verifying those with compatible criteria currently accepted for the diagnosis of bronchiectasis. The medical records of those selected underwent a review process in search of the variables analyzed. Patients diagnosed with cystic fibrosis and with outdated medical records were excluded. Results: Of the 2319 reports studied, 42 patients were identified. Among these, 59.5% were female, 66.7% were followed up at a pneumopediatrics outpatient clinic, and the mean age at the time of imaging diagnosis was 9.3 years (±4.9). At follow-up, 57.1% of patients underwent spirometry and 35.7% underwent sputum culture. The most observed bacterial growth was that of Pseudomonas aeruginosa (33.4%) and the most frequent spirometric pattern was restrictive (29.2%). Of the presumptive etiologies, the most prevalent was recurrent pneumonia (21.4%), followed by bronchiolitis obliterans (14.3%) and collagen diseases (14.3%). Conclusions: The results found in this study allowed a better characterization of this subgroup of patients. In addition, the importance of diagnosing non-cystic fibrosis bronchiectasis is reinforced, as its therapy requires specific and individualized management.